Your Messages Inbox
Your Article Summary
See Latest ArticlesAngiotech pharmaceuticals announces fda 510 clearance of the option inferior vena cava filter
Angiotech Pharmaceuticals, 06/09/09
Angiotech Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has granted 510 clearance for the Option Inferior Vena Cava Filter in the United States, for use in both permanent and retrievable indications. Angiotech holds exclusive worldwide rights to market and distribute the Option IVC Filter, which it obtained in a license agreement with privately held Rex Medical, LP, as previously announced in March 2008.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09
Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09
Harris Corp. Buys VA Contractor
HealthDataManagement, 11/23/09
Article Search
Sponsor